Northern Trust’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.1M Buy
219,401
+6,106
+3% +$291K ﹤0.01% 1966
2025
Q4
$7.97M Sell
213,295
-8,566
-4% -$348K ﹤0.01% 2201
2025
Q3
$8.98M Sell
221,861
-2,661
-1% -$87.9K ﹤0.01% 2174
2025
Q2
$5.73M Sell
224,522
-10,494
-4% -$229K ﹤0.01% 2391
2025
Q1
$5.02M Sell
235,016
-10,094
-4% -$226K ﹤0.01% 2399
2024
Q4
$5.15M Buy
245,110
+16,421
+7% +$380K ﹤0.01% 2492
2024
Q3
$5.15M Buy
228,689
+3,520
+2% +$68K ﹤0.01% 2458
2024
Q2
$3.78M Sell
225,169
-8,913
-4% -$143K ﹤0.01% 2546
2024
Q1
$3.03M Sell
234,082
-9,579
-4% -$115K ﹤0.01% 2758
2023
Q4
$2.82M Buy
243,661
+15,787
+7% +$178K ﹤0.01% 2809
2023
Q3
$2.91M Sell
227,874
-3,627
-2% -$51.4K ﹤0.01% 2732
2023
Q2
$3.17M Sell
231,501
-533
-0.2% -$7.64K ﹤0.01% 2752
2023
Q1
$3.55M Buy
232,034
+4,141
+2% +$63.3K ﹤0.01% 2658
2022
Q4
$3.06M Buy
227,893
+6,298
+3% +$84.5K ﹤0.01% 2767
2022
Q3
$2.94M Sell
221,595
-6,155
-3% -$106K ﹤0.01% 2793
2022
Q2
$4.36M Sell
227,750
-9,632
-4% -$182K ﹤0.01% 2607
2022
Q1
$4.74M Sell
237,382
-4,675
-2% -$94.4K ﹤0.01% 2609
2021
Q4
$4.94M Sell
242,057
-3,559
-1% -$76K ﹤0.01% 2689
2021
Q3
$5.29M Sell
245,616
-17,459
-7% -$420K ﹤0.01% 2694
2021
Q2
$7.6M Sell
263,075
-9,468
-3% -$256K ﹤0.01% 2560
2021
Q1
$6.65M Sell
272,543
-33,086
-11% -$747K ﹤0.01% 2559
2020
Q4
$5.94M Sell
305,629
-11,950
-4% -$220K ﹤0.01% 2574
2020
Q3
$5.53M Sell
317,579
-15,411
-5% -$329K ﹤0.01% 2477
2020
Q2
$8.75M Sell
332,990
-7,418
-2% -$184K ﹤0.01% 2177
2020
Q1
$8.23M Sell
340,408
-2,748
-0.8% -$67.2K ﹤0.01% 1997
2019
Q4
$8.52M Sell
343,156
-14,105
-4% -$327K ﹤0.01% 2280
2019
Q3
$7.62M Sell
357,261
-33,887
-9% -$928K ﹤0.01% 2305
2019
Q2
$12.4M Sell
391,148
-1,864
-0.5% -$58.5K ﹤0.01% 2011
2019
Q1
$13M Sell
393,012
-59,901
-13% -$1.86M ﹤0.01% 1979
2018
Q4
$14.6M Buy
452,913
+33,656
+8% +$1.27M ﹤0.01% 1829
2018
Q3
$18M Buy
419,257
+10,967
+3% +$518K ﹤0.01% 1868
2018
Q2
$18.8M Buy
408,290
+37,946
+10% +$1.68M ﹤0.01% 1827
2018
Q1
$14.7M Buy
370,344
+23,172
+7% +$858K ﹤0.01% 1916
2017
Q4
$11.6M Buy
347,172
+1,555
+0.4% +$55.2K ﹤0.01% 2093
2017
Q3
$12.8M Sell
345,617
-2,313
-0.7% -$86.9K ﹤0.01% 2035
2017
Q2
$12.9M Buy
347,930
+2,545
+0.7% +$83.1K ﹤0.01% 1996
2017
Q1
$9.71M Buy
345,385
+5,385
+2% +$152K ﹤0.01% 2142
2016
Q4
$9.96M Sell
340,000
-111,090
-25% -$3.03M ﹤0.01% 2125
2016
Q3
$12.3M Buy
451,090
+74,541
+20% +$1.69M ﹤0.01% 1930
2016
Q2
$7.03M Buy
376,549
+38,522
+11% +$803K ﹤0.01% 2252
2016
Q1
$9.52M Buy
338,027
+14,280
+4% +$409K ﹤0.01% 2003
2015
Q4
$9.76M Buy
323,747
+10,987
+4% +$353K ﹤0.01% 2032
2015
Q3
$9.89M Buy
312,760
+25,811
+9% +$942K ﹤0.01% 2000
2015
Q2
$11.2M Sell
286,949
-11,614
-4% -$401K ﹤0.01% 1992
2015
Q1
$10.6M Buy
298,563
+36,216
+14% +$1.17M ﹤0.01% 2042
2014
Q4
$8.28M Buy
262,347
+88,033
+51% +$2.43M ﹤0.01% 2160
2014
Q3
$3.91M Buy
174,314
+133,757
+330% +$2.68M ﹤0.01% 2675
2014
Q2
$890K Buy
+40,557
New +$771K ﹤0.01% 3438

Other funds holding PAHC

Northern Trust's PAHC Position: Q1 2026 in Review

Northern Trust increased its Phibro Animal Health (PAHC) stake by 2.9% in Q1 2026, buying an estimated $291K and bringing the position to 219,401 shares worth $12.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1966.

Northern Trust first reported a position in PAHC in Q2 2014 and has held it in 48 quarters since. The position peaked at $18.8M in Q2 2018. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Northern Trust held 219,401 shares of Phibro Animal Health worth $12.1M as of Q1 2026.
  • Northern Trust bought 6,106 Phibro Animal Health shares in Q1 2026, an estimated $291K.
  • Phibro Animal Health made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1966 holding.
  • Northern Trust first reported a position in Phibro Animal Health in Q2 2014 and has held it in 48 quarters since.
  • Northern Trust's Phibro Animal Health position peaked at $18.8M in Q2 2018.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.